# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-015429
Filing Date
2022-05-31
Accepted
2022-05-31 08:05:12
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 14292
2 |  | notice_001.jpg | GRAPHIC | 559208
3 |  | notice_002.jpg | GRAPHIC | 379643
4 |  | notice_003.jpg | GRAPHIC | 3119081
5 |  | notice_004.jpg | GRAPHIC | 579751
| Complete submission text file | 0001493152-22-015429.txt |  | 6398299

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39531 | Film No.: 22980558
SIC: 2834 Pharmaceutical Preparations